1. Up Front

   Up Front 16 March 2020 Pages: 889 - 890

   

2. Diabetic neuropathy: what does the future hold?

   • Brian C. Callaghan
   • Gary Gallagher
   • Eva L. Feldman

   Review 23 January 2020 Pages: 891 - 897

   

3. Streamlined mail-based methods for large randomised trials: lessons learnt from the ASCEND study

   • Marion M. Mafham
   • Louise J. Bowman
   • Jane M. Armitage

   Review Open access 30 November 2019 Pages: 898 - 905

4. Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes

   • Fraser W. Gibb
   • John A. McKnight
   • Mark W. J. Strachan

   Article Open access 07 February 2020 Pages: 906 - 914

   

5. Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort

   • Barnabas Gellen
   • Nathalie Thorin-Trescases
   • on behalf of the SURDIAGENE Study group

   Article 10 February 2020 Pages: 915 - 923

   

6. Improved oral hygiene is associated with decreased risk of new-onset diabetes: a nationwide population-based cohort study

   • Yoonkyung Chang
   • Ji Sung Lee
   • Tae-Jin Song

   Article 02 March 2020 Pages: 924 - 933

   

7. Effect of familial diabetes status and age at diagnosis on type 2 diabetes risk: a nation-wide register-based study from Denmark

   • Omar Silverman-Retana
   • Adam Hulman
   • Daniel R. Witte

   Article 19 February 2020 Pages: 934 - 943

   

8. Impact of diabetes on colorectal cancer stage and mortality risk: a population-based cohort study

   • Judy K. Qiang
   • Rinku Sutradhar
   • Lorraine L. Lipscombe

   Article 28 January 2020 Pages: 944 - 953

   

9. Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults

   • Xiaobo Peng
   • Zihui Xu
   • Liegang Liu

   Article 07 February 2020 Pages: 954 - 963

   

10. Childhood type 1 diabetes: an environment-wide association study across England

    • Annalisa Sheehan
    • Anna Freni Sterrantino
    • Susan Hodgson

    Article Open access 24 January 2020 Pages: 964 - 976

    

11. Neurocognitive impairment in type 2 diabetes: evidence for shared genetic aetiology

    • Josephine Mollon
    • Joanne E. Curran
    • David C. Glahn

    Article 04 February 2020 Pages: 977 - 986

    

12. Extracellular HMGB1 exacerbates autoimmune progression and recurrence of type 1 diabetes by impairing regulatory T cell stability

    • Jing Zhang
    • Longmin Chen
    • Cong-Yi Wang

    Article Open access 19 February 2020 Pages: 987 - 1001

    

13. The glucose-lowering effects of α-glucosidase inhibitor require a bile acid signal in mice

    • Yixuan Qiu
    • Linyan Shen
    • Yanyun Gu

    Article Open access 08 February 2020 Pages: 1002 - 1016

    

14. Metabolic alterations in immune cells associate with progression to type 1 diabetes

    • Partho Sen
    • Alex M. Dickens
    • Matej Orešič

    Article Open access 11 February 2020 Pages: 1017 - 1031

    

15. Associations of dicarbonyl stress with complement activation: the CODAM study

    • Ying Xin
    • Elisabeth Hertle
    • Marleen M. J. van Greevenbroek

    Article Open access 28 January 2020 Pages: 1032 - 1042

    

16. Glucose-dependent insulinotropic peptide and risk of cardiovascular events and mortality: a prospective study

    • Amra Jujić
    • Naeimeh Atabaki-Pasdar
    • Martin Magnusson

    Article Open access 23 January 2020 Pages: 1043 - 1054

    

17. Impaired counterregulatory responses to hypoglycaemia following oral glucose in adults with cystic fibrosis

    • Moira L. Aitken
    • Magdalena A. Szkudlinska
    • Steven E. Kahn

    Article 29 January 2020 Pages: 1055 - 1065

    

18. Influence of cardiac autonomic neuropathy on cardiac repolarisation during incremental adrenaline infusion in type 1 diabetes

    • Alan Bernjak
    • Elaine Chow
    • Simon R. Heller

    Short Communication Open access 07 February 2020 Pages: 1066 - 1071

    

19. Akap1 deficiency exacerbates diabetic cardiomyopathy in mice by NDUFS1-mediated mitochondrial dysfunction and apoptosis

    • Bingchao Qi
    • Linjie He
    • Lele Ji

    Article 19 February 2020 Pages: 1072 - 1087

    

20. Correction to: Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

    • Pablo Aschner
    • Juan J. Gagliardino
    • Juliana C. N. Chan

    Correction 06 March 2020 Pages: 1088 - 1089

21. Correction to: PAM haploinsufficiency does not accelerate the development of diet and human IAPP-induced diabetes in mice

    • Yi-Chun Chen
    • Richard E. Mains
    • C. Bruce Verchere

    Correction 14 March 2020 Pages: 1090 - 1090